Androgen receptor mutations in androgen-independent prostate cancer: Cancer and leukemia group B study 9663

Journal of Clinical Oncology

Volumn 21, Issue 14, 2003, Pages 2673-2678

  Taplin, Mary Ellen ^a   Rajeshkumar, Barur ^a   Halabi, Susan ^a   Werner, Cary P ^a   Woda, Bruce A ^a   Picus, Joel ^a   Stadler, Walter ^a   Hayes, Daniel F ^a   Kantoff, Philip W ^a   Vogelzang, Nicholas J ^a   Small, Eric J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; DNA; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR; ANTIANDROGEN; TUMOR MARKER;

ARTICLE; BONE MARROW BIOPSY; CHEMOTHERAPY; CLINICAL TRIAL; GENE MUTATION; GENE SEQUENCE; HORMONAL THERAPY; HORMONE BINDING; HUMAN; LEUKEMIA; MALE; MICROSCOPY; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE ANALYSIS; TREATMENT FAILURE; ADENOCARCINOMA; AGED; BLOOD; BONE MARROW; CANCER STAGING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETICS; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MOLECULAR GENETICS; MORTALITY; MUTATION; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHASE 3 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; BASE SEQUENCE; BIOPSY, NEEDLE; BONE MARROW; CONFIDENCE INTERVALS; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0042130389     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.11.102     Document Type: Article

References (29)

1. Kyorianou N, Isaacs JT: Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562, 1988
2. Eisenberger MA, Blumenstein BA, Crawford ED, et al: Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med 339:1036-1042, 1998
3. Small EJ, Vogelzang NJ: Second-line hormonal therapy for advanced prostate cancer: A shifting paradigm. J Clin Oncol 15:382-386, 1997
4. Scher HI, Kelly WK: Flutamide withdrawal syndrome: Its impact on clinical trials in hormone-refractory prostate cancer. J Clin Oncol 11:1566-1572, 1993
5. Kelly WK, Slovin S, Scher HI: Steroid hormone withdrawal syndromes pathophysiology and clinical significance. Urol Clin North Am 24:421-431, 1997
6. De Vere White R, Meyers F, Chi SG, et al: Human androgen receptor expression in prostate cancer following androgen ablation. Eur Urol 31:1-6, 1997
7. Ruizeveld De Winter JA, Trapman J, Vermey M, et al: Androgen receptor expression in human tissues: An immunohistochemical study. J Histochem Cytochem 39:927-936, 1991
8. Koivisto P, Kononen J, Palmberg C, et al: Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 57:314-319, 1997
9. Schoenberg MP, Hakimi JM, Wang S, et al: Microsatellite mutation (CAG24-18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 198:74-80, 1994
10. Taplin M-E, Bubley GJ, Ko Y-J, et al: Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res 59:2511-2515, 1999
11. Newmark JR, Hardy DO, Tonb DC, et al: Androgen receptor gene mutations in human prostate cancer. PNAS 89:6319-6323, 1992
12. Marcelli M, Ittmann M, Mariani S, et al: Androgen receptor mutations in prostate cancer. Cancer Res 60:944-949, 2000
13. Taplin M-E, Bubley GJ, Shuster T, et al: Mutation of the androgen receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393-1398, 1995
14. Gottlieb B, Lehvaslaiho H, Beitel LK, et al: Androgen receptor gene mutations database. Nucleic Acids Res 26:234-238, 1998
15. Gelmann EP: Molecular biology of the androgen receptor. J Clin Oncol 20:3001-3015, 2002
16. Fenton MA, Shuster TD, Fertig AM, et al: Functional characterization of mutant androgen receptors from androgen-independent prostate cancer. Clin Cancer Res 3:1383-1388, 1997
17. Veldscholte JC, Kuiper GGJM, Jenster G, et al: A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173:534-540, 1990
18. Culig Z, Hobisch A, Cronauer MV, et al: Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7:1541-1550, 1993
19. Zhao X-Y, Malloy PJ, Krishnan AV, et al: Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 6:703-706, 2000
20. Gussow D, Rein R, Ginjaar I, et al: The human beta2-microglobulin gene: Primary structure and definition of the transcriptional unit. J Immunol 139:3132-3138, 1987
21. Berrevoets CA, Doesburg P, Steketee K, et al: Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2). Mol Endocrinol 12:1172-1183, 1998
22. Tilley WD, Buchanan G, Hickey TE, et al: Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res 2:277-285, 1996
23. Joyce R, Fenton MA, Rode P, et al: High dose bicalutamide for androgen independent prostate cancer: Effect of prior hormonal therapy. J Urol 159:149-153, 1998
24. Matias PM, Donner P, Coelho R, et al: Structural evidence for ligand specificity in the binding domain of the human androgen receptor: Implications for pathogenic gene mutations. J Biol Chem 275:26164-26171, 2000
25. Buchanan G, Greenberg NM, Scher HI, et al: Collocation of androgen receptor gene mutations in prostate cancer. Clin Cancer Res 7:1273-1281, 2001
26. Takahashi H, Furusato M, Allsbrook WC, et al: Prevalence of androgen receptor gene mutations in latent prostatic carcinomas. Cancer Res 55:1621-1624, 1995
27. Suzuki H, Sato N, Watabe Y, et al: Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 46:759-765, 1993
28. Wallen MJ, Linja MJ, Kaartinen K, et al: Androgen receptor gene mutation in hormone-refractory prostate cancer. J Pathol 189:559-563, 1999
29. Caskey CT, Pizzuti A, Fu Y-H, et al: Triplet repeat mutations in human disease. Science 256:784-789, 1992